Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757083011 | Lorlatinib only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3757085016 | Product containing only lorlatinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lorlatinib only product in oral dose form | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Lorlatinib only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Lorlatinib only product in oral dose form | Is a | Product containing only lorlatinib (medicinal product) | true | Inferred relationship | Some | ||
| Lorlatinib only product in oral dose form | Is a | Product containing lorlatinib in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Lorlatinib only product in oral dose form | Has active ingredient | Lorlatinib | true | Inferred relationship | Some | 1 | |
| Lorlatinib only product in oral dose form | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely lorlatinib 100 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Lorlatinib only product in oral dose form | Inferred relationship | Some | |
| Lorlatinib 25 mg oral tablet | Is a | True | Lorlatinib only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR